Home
Browse All Titles
Sign In
Browse All Titles
Radiation Oncology Question Review
About
Table of Contents
Main Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
A
B
C
D
E
F
G
H
I
L
M
N
O
P
R
S
T
U
V
W
X
▶
View All
Adjuvant Navelbine International Trialist Association (ANITA) trial
Amifostine
Answer 1.12
Question 1.12
Anal cancer
Anaplastic gliomas
anaplastic oligodendrogliomas
chemotherapy
radiation therapy for
treatment for
1p19q deletion, impact of
bromodeoxyuridine (BUdR) therapy
incidence rate
temozolomide in
Arteriovenous malformation
implications for not treating
Spetzler-martin grading scheme
toxicities associated with SRS
risk of hemorrhage following radiosurgery
stereotactic radiosurgery (SRS)
Bevacizumab
Question 2.101
Answer 2.101
Bilateral diagnostic mammogram
Question 3.26
Question 3.25
Bladder cancer
adenocarcinoma of, site for
chemoRT, OS for
cisplatinum-based chemoradiation
neoadjuvant chemotherapy
TN staging
treatment planning with radiation
bladder preservation treatment
chemotherapy to definitive radiation
contraindications with chemoradiation
patients outcomes with
transitional cell carcinoma of, site for
Brachytherapy
Answer 7.115
ICRU Report
Question 7.115
Answer 7.114
GEC-eSTRO dose guidelines
LDR vs HDR
Brainstem gliomas in children and adolescents
chemotherapy
incidence rate
radiation therapy
hyperfractionation
prognostic factors
bromodeoxyuridine (BUdR) therapy
Cardiac tumors
common
median survival rate
toxicities with irradiation therapy
adjuvant radiation therapy
management
primary pericardial tumor
Cetuximab dose
Chemoradiation
Question 1.12_2
Answer 1.12_2
Cholangiocarcinoma
higher risk factor for recurrence
incidence rate
radiation therapy for
risk factors for
signs and symptoms
histologic variant
mayo clinic liver transplant selection criteria and protocol
resectability of
role for SBRT in
CNS radiation toxicities/therapies for toxicities
Cahan's criteria for radiation-induced neoplasm
donepezil
methylphenidate
risk of optic neuropathy
bevacizumab
classification of radiation injury
following radiation of spinal cord
phenytoin
Craniopharyngioma
endocrine abnormalities
incidence rate
primary management
radiation therapy
resection of
cyst management
histologies
long-term outcomes of
prognostic features
radiosurgery (SRS)
survival rates
craniospinal irradiation (CSI)
cyclophosphamide, doxorubicin, vincristine, and dexamethasone (CHOD) chemotherapy
Answer 2.69
Question 2.69
Donepezil
Answer 2.100
Question 2.100
Early Lung Cancer Action Project (ELCAP)
ELCAP
Ependymoma
common location for pediatric
intracranial
pathological features
radiation therapy
adjuvant conformal radiotherapy, outcome of
histological subtypes
location for
prognostic factors
surgical resection treatment, outcome of
Esophageal cancer
Ewing's sarcoma
incidence rate
osteosarcoma and
prognostic factors
treatment approach
cellular morphology
local vs metastatic, survival rate
phase III INT-0091 study
radiographic findings
Follicular Lymphoma International Prognostic Index (FLIPI)
Answer 8.18
Answer 8.20
Answer 8.19
germ cell tumors (CNS)
signs/symptoms
treatment
germ cell tumors (non-CNS)
anatomical sites for extragonadal
choriocarcinomas
histological subtypes
radiotherapy for extragonadal
teratomas
chemotherapy
germinomas
optimal surgical procedure
retroperitoneal dissection
yolk sac tumors
glioblastoma
Graded Prognostic Assessment (GPA)
Answer 2.8
Question 2.8
Refresh
first
prev
1
2
3
4
5
30
select
next
last
Displaying items 1 - 30 of 145